TechConnect Innovation Program

Chemotherapy wafer to treat oral cancer topically

Privo Technologies, MA, United States

TECHNOLOGY SUMMARY

Our ChemoThin Wafer (CTW) is a polymeric mesh that hold chemotherapy nano-particles. upon hydration, it releases the nano particles along with other excipients directly into the tumor. The CTW is unidirectional mucoadhesive wafer that remain in place and can be removed after one hour of appliction.

Primary Application Area: Biotech & Biological Sciences

Technology Development Status: Prototype

Technology Readiness Level: TRL 4

FIGURES OF MERIT

Value Proposition: Our wafer is intended to be placed topically directly on the tumor in the oral cavity. It has shown very promising results in our in-vivo studies. The results show high efficacy due to high concentration of the anit-cancer drug in the tumor with limited systemic exposure and side effects.

SHOWCASE SUMMARY

Organization Type: Early-stage Startup (Seed)

National Innovation Awardee

Showcase Booth #: 51T

Website: www.PrivoTechnologies.com

GOVT/EXTERNAL FUNDING SOURCES

Government Funding/Support to Date:

Primary Sources of Funding: Angel, Friends, Family, Corporate Partner, Federal Grant

Looking for: Both Funding and Development Partners